CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-28 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −3,250 | $454.79 | $1.5M | 50,387 |
| 2024-05-24 | Kewalramani Reshma CEO & President | Exercise or conversion 10b5-1 | +1,565 | $187.53 | $293K | 122,939 |
| 2024-05-24 | Kewalramani Reshma CEO & President | Sale 10b5-1 | −1,565 | $457.00 | $715K | 121,374 |
| 2024-05-24 | Kewalramani Reshma CEO & President | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,565 | 0 | ||
| 2024-05-22 | SACHS BRUCE I Director | Exercise or conversion 10b5-1 | +7,073 | $93.51 | $661K | 47,073 |
| 2024-05-22 | SACHS BRUCE I Director | Sale 10b5-1 | −7,073 | $448.00 | $3.2M | 40,000 |
| 2024-05-22 | SACHS BRUCE I Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −7,073 | 0 | ||
| 2024-05-20 | Kewalramani Reshma CEO & President | Sale 10b5-1 | −15,202 | $447.00 | $6.8M | 121,374 |
| 2024-05-15 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −32 | $430.93 | $14K | 55,325 |
| 2024-05-15 | Arbuckle Stuart A EVP, COO | Sale 10b5-1 | −69 | $430.93 | $30K | 49,691 |
| 2024-05-15 | ALTSHULER DAVID EVP, Chief Scientific Officer | Sale 10b5-1 | −54 | $430.93 | $23K | 25,813 |
| 2024-05-15 | Schneider Jennifer Director | Grant or award | +922 | 922 | ||
| 2024-05-14 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Grant or award | +14,112 | 30,084 | ||
| 2024-05-02 | Bhatia Sangeeta N. Director | Sale 10b5-1 | −467 | $402.95 | $188K | 4,435 |
| 2024-05-01 | Upadhyay Suketu Director | Grant or award | +1,001 | 3,727 | ||
| 2024-05-01 | Upadhyay Suketu Director | Returned to the company | −1,168 | 2,559 | ||
| 2024-05-01 | Upadhyay Suketu Director | Grant or award · Deferred Stock Units | +1,168 | 1,403 | ||
| 2024-05-01 | Thornberry Nancy Director | Grant or award | +501 | 1,637 | ||
| 2024-05-01 | Thornberry Nancy Director | Grant or award · Stock Option (Right to Buy) | +1,571 | 1,571 | ||
| 2024-05-01 | SACHS BRUCE I Director | Grant or award · Stock Option (Right to Buy) | +3,142 | 3,142 |
Page 20 of 27 · 524 trades